Approved Formulary
Add Formweb to your mobile device
Approved Formulary
HIGH ALERT: Please read the COMMENTS very carefully.
Do Not Crush may be crushed, but must be administered within 4 hours
Black Box Warning: Premature discontinuation increases the risk of thrombotic events
Search results for:
RIVAROXABAN
RIVAROXABAN
High Alert Drug
Last updated: Apr. 22, 2023
- Do Not Crush may be crushed, but must be administered within 4 hours
- Black Box Warning: Premature discontinuation increases the risk of thrombotic events
See guidelines for use and management
Renal dosing removed temporarily, refer to Renal Dosing Policy via Policy Finder on GHS Connect
Reversal of Anticoagulants
Anticoagulation Alerts Chart
Emergent Reversal
The Anticoagulation Management Program may be found by using the search function in Policies and Procedures.
The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.